Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Guided Therapeutics, Inc.

Market Cap 19.57M 16.91M 15.58M 14.58M 27.33M 1.86B 27.75M 184M 71.72M 906M 73.46M 71.89M 3.14B P/E Ratio 2024
-3x
P/E Ratio 2025 -12.7x
Enterprise Value 22.45M 19.39M 17.87M 16.72M 31.34M 2.13B 31.83M 211M 82.26M 1.04B 84.25M 82.46M 3.6B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 day+1.38%
1 week+1.40%
Current month-11.44%
1 month+1.40%
3 months-30.07%
6 months-24.89%
Current year-62.44%
1 week 0.18
Extreme 0.1805
0.2
1 month 0.18
Extreme 0.18
0.23
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
9,280
Manager TitleAgeSince
Chief Executive Officer 70 05/03/2023
Chief Tech/Sci/R&D Officer 70 01/12/2010
Director TitleAgeSince
Director/Board Member 70 30/11/2016
Director/Board Member 76 09/04/2006
Chairman 67 30/09/2013
Date Insider Type Main position Quantity % Market Cap.
03-09Others

Director

10 0.9747%
03-09Free

Chairman

110,000 0.1316%
03-09Free

Director

110,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
+1.38%+1.40%+6.74%+23.36% 19.57M
-1.33%-0.73%+13.00%-10.38% 174B
-0.45%-2.61%-19.87%+31.06% 146B
-0.38%-2.28%-12.19%-24.34% 127B
-0.55%-3.38%-52.40%-8.38% 69.72B
-0.76%-0.99%+12.15%-0.54% 49.01B
+0.67%-0.60%-25.38%-34.31% 44.74B
+0.22%-4.13%+9.19%+9.53% 36.67B
-1.17%-2.69%+1.70%+38.38% 34.91B
+1.04%+0.79%-10.85%-16.72% 29.65B
Average -0.13%-1.89%-7.79%+0.77% 71.22B
Weighted average by Cap. -0.55%-1.98%-8.84%-1.89%

Financials

2024 2025
Net sales 7K 6.05K 5.57K 5.22K 9.77K 665K 9.92K 65.78K 25.65K 324K 26.27K 25.71K 1.12M 767K 662K 610K 571K 1.07M 72.9M 1.09M 7.21M 2.81M 35.49M 2.88M 2.82M 123M
Net income -2.42M -2.09M -1.92M -1.8M -3.37M -230M -3.43M -22.71M -8.86M -112M -9.07M -8.88M -387M -3.2M -2.76M -2.54M -2.38M -4.46M -304M -4.53M -30.04M -11.71M -148M -11.99M -11.74M -512M
Net Debt 1.77M 1.53M 1.41M 1.32M 2.47M 168M 2.51M 16.64M 6.49M 81.93M 6.65M 6.51M 284M 2.88M 2.48M 2.29M 2.14M 4.02M 273M 4.08M 27.03M 10.54M 133M 10.79M 10.56M 461M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
10/06/26 0.2028 $ +1.38% 2,919
05/06/26 0.2000 $ -12.28% 11,300
  1. Stock Market
  2. Stocks
  3. GTHP Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!